Pathology Microbiology And Immunology
-
VUMC investigators find pathogens work together to infect host
Pseudomonas aeruginosa and Staphylococcus aureus — two pathogens that frequently co-infect the lungs of patients with cystic fibrosis — appear to cooperate with each other, Vanderbilt investigators have discovered. When pseudomonas is starved for metal by the host, it shuts down the production of factors that would normally kill staph, promoting a co-infection. Read MoreNov 3, 2016
-
Preparing for a return of pox
To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people. Read MoreOct 20, 2016
-
Research sheds light on how RSV wards off potential vaccines
Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it. Read MoreOct 20, 2016
-
EGF receptor found to regulate macrophage inflammation in gut
Researchers at Vanderbilt University School of Medicine have uncovered a link between epidermal growth factor receptor (EGFR) signaling and the inflammatory response to bacterial infection in the gastrointestinal tract. Read MoreOct 13, 2016
-
Targeting norovirus “noxiousness”
New discoveries will guide efforts to develop vaccines or antiviral agents for norovirus, the most common cause of infectious diarrhea. Read MoreSep 28, 2016
-
Study shows excess dietary zinc worsens C. diff infection
Too much dietary zinc increases susceptibility to infection by Clostridium difficile — “C. diff” — the most common cause of hospital-acquired infections. Read MoreSep 26, 2016
-
H. pylori and anemia – new evidence
The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide. Read MoreSep 22, 2016
-
Study explores anti-viral potential of existing drugs
Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market. Read MoreSep 15, 2016
-
Restore T cells to fight leukemia
Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients. Read MoreSep 14, 2016
-
Team explores transcription factor’s autoimmunity role
Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently. Read MoreAug 11, 2016
-
Study explores low oxygen’s impact on antibody quality
Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order. Read MoreAug 11, 2016
-
These days, fecal transplantation is no joke
Fecal transplants are increasingly being used to treat certain human illnesses and more scientists have begun to research the transplants' effects in animals. Read MoreJul 12, 2016
-
‘Young Scientist’ showcases high schoolers’ research at Vanderbilt
High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own. Read MoreJun 2, 2016
-
VUMC researchers seek to crack the code of neonatal sepsis
Sepsis, an exaggerated and overwhelming inflammatory response to infection, is a major worldwide killer of babies in the first four weeks of life (neonatal period). Read MoreJun 2, 2016
-
Wound healing society honors VUMC’s Davidson
Jeff Davidson, Ph.D., professor of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, was honored last month at the joint 27th annual Symposium on Advanced Wound Care and Wound Healing Society meeting in Atlanta for “outstanding lifetime achievement in wound healing.” Read MoreMay 26, 2016
-
Improving natural killer cancer therapy
A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies. Read MoreApr 29, 2016
-
An Argonaute’s voyage to cancer
A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.” Read MoreApr 28, 2016
-
Immune defenses in asthma
Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease. Read MoreApr 5, 2016
-
Zutter takes part in cancer strategy meet at White House
Vanderbilt physician/scientist Mary Zutter, M.D., Louise B. McGavock Professor of Pathology, Microbiology and Immunology and assistant vice chancellor for Integrative Diagnostics, can now add “White House guest” to her resume. Read MoreFeb 4, 2016
-
Study identifies new culprit in lung cancer development
A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered. Read MoreJan 27, 2016